• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组学分析人类子宫内膜组织揭示了 PI3K/AKT/mTOR 通路和肿瘤血管生成分子在子宫内膜癌发病机制中的作用。

Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.

机构信息

Department of Obstetrics & Gynecology, Tianjin Medical University, Tianjin 300070, China.

Department of Gynecology, Chifeng Municipal Hospital, Chifeng Clinical Medical School of Inner Mongolia Medical University, Chifeng 024000, China.

出版信息

Biomed Res Int. 2020 Aug 22;2020:5273969. doi: 10.1155/2020/5273969. eCollection 2020.

DOI:10.1155/2020/5273969
PMID:32908897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7463404/
Abstract

As one major gynecological malignancy, endometrial cancer (EC) has been widely studied recently. However, its pathogenesis is still unclear to date. In this study, we identified differentially expressed proteins between 30 endometrial cancer tissues and 30 matched normal controls using 2D LC-MS/MS quantitative proteomics. As a result, we identified 619 differentially expressed proteins among all 2521 proteins being quantified. Further analyses suggested that the changes of fat, amino acid metabolism, peroxisome, extracellular signal, cytoskeleton, and other signaling or metabolic pathways may be closely related to the development of this cancer. Particularly, the PI3K/AKT/mTOR pathway-related molecules including PI3K and mTOR, ERK (the molecule of the ERK pathway), SPP1, and ANGPT2 (angiogenesis-related molecules) are highly associated with the pathogenesis of EC, which were reconfirmed by western blot and immunohistochemistry (IHC) analysis. In summary, our study revealed that the PI3K/AKT/mTOR pathway and tumor angiogenesis molecules contribute to the pathogenesis of endometrial cancer.

摘要

作为一种主要的妇科恶性肿瘤,子宫内膜癌(EC)最近得到了广泛研究。然而,其发病机制迄今仍不清楚。在这项研究中,我们使用二维液相色谱-串联质谱定量蛋白质组学技术,鉴定了 30 例子宫内膜癌组织和 30 例匹配的正常对照之间的差异表达蛋白。结果,我们在所有被定量的 2521 种蛋白质中鉴定出 619 种差异表达蛋白。进一步分析表明,脂肪、氨基酸代谢、过氧化物酶体、细胞外信号、细胞骨架和其他信号或代谢途径的变化可能与这种癌症的发展密切相关。特别是,PI3K/AKT/mTOR 通路相关分子,包括 PI3K 和 mTOR、ERK(ERK 通路的分子)、SPP1 和 ANGPT2(血管生成相关分子),与 EC 的发病机制高度相关,这通过 Western blot 和免疫组织化学(IHC)分析得到了进一步证实。总之,我们的研究揭示了 PI3K/AKT/mTOR 通路和肿瘤血管生成分子有助于子宫内膜癌的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/405f38c8b661/BMRI2020-5273969.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/ca7ecead7cdc/BMRI2020-5273969.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/b9dabb0a2172/BMRI2020-5273969.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/8b2c529f99ad/BMRI2020-5273969.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/405f38c8b661/BMRI2020-5273969.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/ca7ecead7cdc/BMRI2020-5273969.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/b9dabb0a2172/BMRI2020-5273969.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/8b2c529f99ad/BMRI2020-5273969.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fa9/7463404/405f38c8b661/BMRI2020-5273969.004.jpg

相似文献

1
Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.蛋白质组学分析人类子宫内膜组织揭示了 PI3K/AKT/mTOR 通路和肿瘤血管生成分子在子宫内膜癌发病机制中的作用。
Biomed Res Int. 2020 Aug 22;2020:5273969. doi: 10.1155/2020/5273969. eCollection 2020.
2
MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.微小RNA-29b通过靶向血管内皮生长因子A,经由丝裂原活化蛋白激酶/细胞外信号调节激酶和磷脂酰肌醇-3-激酶/蛋白激酶B信号通路抑制子宫内膜癌血管生成。
Cell Physiol Biochem. 2017;41(3):933-946. doi: 10.1159/000460510. Epub 2017 Feb 20.
3
Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.人参皂苷Rg3通过VEGFR - 2介导的PI3K/Akt/mTOR信号通路抑制子宫内膜异位症大鼠模型中的血管生成。
PLoS One. 2017 Nov 15;12(11):e0186520. doi: 10.1371/journal.pone.0186520. eCollection 2017.
4
Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and mTOR in endometrial cancer.PI3K/Akt/mTOR 通路的激活和 PI3K/mTOR 的双重抑制剂在子宫内膜癌中的作用。
Curr Med Chem. 2014;21(26):3070-80. doi: 10.2174/0929867321666140414095605.
5
The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.PI3K/AKT/mTOR 通路作为子宫内膜癌的治疗靶点。
Clin Cancer Res. 2012 Nov 1;18(21):5856-64. doi: 10.1158/1078-0432.CCR-12-0662. Epub 2012 Oct 18.
6
Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.敲低 FAM83B 通过沉默 PI3K/AKT/mTOR 通路抑制子宫内膜癌细胞增殖和转移。
Biomed Pharmacother. 2019 Jul;115:108939. doi: 10.1016/j.biopha.2019.108939. Epub 2019 May 9.
7
Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling.二甲双胍通过抑制PI3K/AKT/mTOR信号传导,与人类子宫内膜癌中细胞增殖的减少有关。
Gynecol Endocrinol. 2018 May;34(5):428-432. doi: 10.1080/09513590.2017.1409714. Epub 2017 Nov 28.
8
MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway.MLLT11-TRIL 复合物通过 PI3K/AKT/mTOR 信号通路促进子宫内膜癌的进展。
Cancer Biol Ther. 2022 Dec 31;23(1):211-224. doi: 10.1080/15384047.2022.2046450.
9
Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.通过组蛋白去乙酰化酶和 PI3K/AKT/mTOR 信号靶向子宫内膜间质肉瘤细胞的作用。
Anticancer Res. 2014 Jun;34(6):2883-97.
10
nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans.nm23通过PI3K-Akt-mTOR信号通路调节小鼠和人类的蜕膜化过程。
Hum Reprod. 2016 Oct;31(10):2339-51. doi: 10.1093/humrep/dew191. Epub 2016 Sep 7.

引用本文的文献

1
ITRAQ Based Proteomics Reveals the Potential Mechanism of Placental Injury Induced by Prenatal Stress.基于 iTRAQ 的蛋白质组学揭示了产前应激致胎盘损伤的潜在机制。
Int J Mol Sci. 2024 Sep 16;25(18):9978. doi: 10.3390/ijms25189978.
2
Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions.关注蛋白激酶 mTOR 在子宫内膜生理和病理中的作用:治疗干预的见解。
Mol Biol Rep. 2024 Feb 24;51(1):359. doi: 10.1007/s11033-023-08937-w.
3
Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.

本文引用的文献

1
Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis.比较蛋白质组学揭示了用于诊断肺头颈部癌症转移的特征性生物标记物。
EMBO Mol Med. 2018 Sep;10(9). doi: 10.15252/emmm.201708428.
2
Proteomics Analysis of Colorectal Cancer Cells.结肠癌细胞的蛋白质组学分析
Methods Mol Biol. 2018;1765:155-166. doi: 10.1007/978-1-4939-7765-9_9.
3
Proteomics analysis of human placenta reveals glutathione metabolism dysfunction as the underlying pathogenesis for preeclampsia.蛋白质组学分析人类胎盘揭示谷胱甘肽代谢功能障碍是子痫前期的潜在发病机制。
使用无偏蛋白质组学方法鉴定子宫内膜癌潜在的新型分子靶点。
Cancers (Basel). 2023 Sep 21;15(18):4665. doi: 10.3390/cancers15184665.
4
Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.基于蛋白质组学、代谢组学和临床数据的子宫内膜癌诊断与预后算法:一项系统综述
Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023.
5
Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics.基于反向虚拟筛选和蛋白质组学的甘草查尔酮 B 对人结肠癌细胞系 SW480 和 SW620 增殖、凋亡和迁移的影响及其机制研究。
Oxid Med Cell Longev. 2023 Jan 5;2023:1117431. doi: 10.1155/2023/1117431. eCollection 2023.
6
mA mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer.mA mRNA 甲基化通过 PAPPA/IGFBP4 轴调控 ERK/NF-κB/AKT 信号通路,促进子宫内膜癌的增殖和肿瘤形成。
Cell Biol Toxicol. 2023 Aug;39(4):1611-1626. doi: 10.1007/s10565-022-09751-z. Epub 2022 Aug 15.
7
Ipatasertib, an oral AKT inhibitor, inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancer.依帕替尼,一种口服的AKT抑制剂,可抑制浆液性子宫内膜癌的细胞增殖和迁移,并诱导细胞凋亡。
Am J Cancer Res. 2022 Jun 15;12(6):2850-2862. eCollection 2022.
8
Treatment effect of DNA framework nucleic acids on diffuse microvascular endothelial cell injury after subarachnoid hemorrhage.DNA 框架核酸对蛛网膜下腔出血后弥漫性微血管内皮细胞损伤的治疗作用。
Cell Prolif. 2022 Apr;55(4):e13206. doi: 10.1111/cpr.13206. Epub 2022 Feb 21.
9
Integrated Transcriptome and Multiple Activated Pathways in Endometrial Cancer.子宫内膜癌中的综合转录组与多种激活途径
Front Genet. 2021 Dec 3;12:680331. doi: 10.3389/fgene.2021.680331. eCollection 2021.
10
Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways.作为靶向癌症驱动信号通路关键因子的抗肿瘤剂的多酚类物质。
Front Pharmacol. 2021 Oct 20;12:710304. doi: 10.3389/fphar.2021.710304. eCollection 2021.
Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1207-1214. doi: 10.1016/j.bbapap.2017.07.003. Epub 2017 Jul 10.
4
Impact of Amidination on Peptide Fragmentation and Identification in Shotgun Proteomics.脒基化对鸟枪法蛋白质组学中肽段片段化及鉴定的影响
J Proteome Res. 2016 Oct 7;15(10):3656-3665. doi: 10.1021/acs.jproteome.6b00468. Epub 2016 Sep 27.
5
GOplot: an R package for visually combining expression data with functional analysis.GOplot:一个用于将表达数据与功能分析进行可视化整合的R软件包。
Bioinformatics. 2015 Sep 1;31(17):2912-4. doi: 10.1093/bioinformatics/btv300. Epub 2015 May 11.
6
Proteomics analysis of bodily fluids in pancreatic cancer.胰腺癌患者体液的蛋白质组学分析
Proteomics. 2015 Aug;15(15):2705-15. doi: 10.1002/pmic.201400476. Epub 2015 Apr 27.
7
The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges.卵巢癌中的PI3K/Akt/mTOR信号通路:治疗机遇与挑战
Chin J Cancer. 2015 Jan;34(1):4-16. doi: 10.5732/cjc.014.10289.
8
High-throughput proteomics.高通量蛋白质组学
Annu Rev Anal Chem (Palo Alto Calif). 2014;7:427-54. doi: 10.1146/annurev-anchem-071213-020216.
9
Role of aberrant PI3K pathway activation in gallbladder tumorigenesis.异常PI3K信号通路激活在胆囊肿瘤发生中的作用。
Oncotarget. 2014 Feb 28;5(4):894-900. doi: 10.18632/oncotarget.1808.
10
PI3K and cancer: lessons, challenges and opportunities.PI3K 与癌症:教训、挑战与机遇。
Nat Rev Drug Discov. 2014 Feb;13(2):140-56. doi: 10.1038/nrd4204.